{
 "id": "colorectal-cancer",
 "name": "Colorectal cancer",
 "aliases": [
  "Colorectal Carcinoma"
 ],
 "acronyms": [],
 "bodySystem": "cancer",
 "parent": null,
 "children": [
  "metastatic-colorectal-cancer"
 ],
 "edition": "2026-11",
 "merkleRoot": "006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6",
 "builtFrom": "program.status and program.eligibility facts, grouped by the condition registry",
 "counts": {
  "open": 0,
  "limited": 0,
  "waitlist": 0,
  "closed": 2
 },
 "funds": [
  {
   "fund": "Colorectal Carcinoma - Medicare Access",
   "organization": "HealthWell Foundation",
   "status": "closed",
   "dateOnPage": null,
   "awardLevelUsd": null,
   "insuranceTypes": null,
   "pageSays": "The page lists the fund as Closed.",
   "readOn": "2026-11-08",
   "source": "https://www.healthwellfoundation.org/disease-funds/"
  },
  {
   "fund": "Colorectal cancer",
   "organization": "TotalAssist (Patient Advocate Foundation copay funds)",
   "status": "closed",
   "dateOnPage": null,
   "awardLevelUsd": 5000,
   "insuranceTypes": [
    "Medicaid",
    "Medicare",
    "TRICARE"
   ],
   "pageSays": "The page lists the fund as Closed.",
   "readOn": "2026-11-08",
   "source": "https://totalassist.org/funds/"
  }
 ],
 "drugsWhoseLabelNamesThisCondition": [
  {
   "ingredient": "Encorafenib",
   "pages": [
    {
     "brand": "Braftovi",
     "url": "https://omnirx.org/medicines/braftovi"
    }
   ],
   "labelSentence": "Colorectal Cancer (CRC) • in combination with cetuximab and fluorouracil-based chemotherapy, for the treatment of adult patients with metastatic colorectal cancer (mCRC) with a BRAF V600E mutation ...",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22235dfc38-0f0b-4037-b501-7a9f4294740c%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Pfizer RxPathways (Pfizer Patient Assistance Program)",
     "url": "https://omnirx.org/assistance/pfizer-rxpathways",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": "products remaining within Pfizer PAP as of January 1, 2026",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Regorafenib",
   "pages": [
    {
     "brand": "Stivarga",
     "url": "https://omnirx.org/medicines/stivarga"
    }
   ],
   "labelSentence": "Metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type, an anti-EGFR therapy.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22824f19c9-0546-4a8a-8d8f-c4055c04f7c7%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Bayer US Patient Assistance Foundation",
     "url": "https://www.patientassistance.bayer.us/en/about/bayer-products",
     "programPageIsExternal": true,
     "inCurrentList": true,
     "note": null,
     "listKind": "Bayer prescription medicines included in the program",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Sotorasib",
   "pages": [
    {
     "brand": "Lumakras",
     "url": "https://omnirx.org/medicines/lumakras"
    }
   ],
   "labelSentence": "KRAS G12C-mutated Metastatic Colorectal Cancer (mCRC) In combination with panitumumab, for the treatment of adult patients with KRAS G12C-mutated mCRC as determined by an FDA approved-test, who have received prior ...",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22c80a362c-7ac3-4894-a076-0691e68ef8c1%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Amgen Safety Net Foundation",
     "url": "https://www.amgensafetynetfoundation.com/eligibility.html",
     "programPageIsExternal": true,
     "inCurrentList": true,
     "note": null,
     "listKind": "Eligibility page medication selector (tile titles)",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Fruquintinib",
   "pages": [
    {
     "brand": "Fruzaqla",
     "url": "https://omnirx.org/medicines/fruzaqla"
    }
   ],
   "labelSentence": "FRUZAQLA is indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild‑type and ...",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22186d786e-dc8a-45f2-b5e1-01ac0201879f%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Trifluridine/Tipiracil HCl",
   "pages": [],
   "labelSentence": "... metastatic colorectal cancer as a single agent or in combination with bevacizumab who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF ...",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22f5beed22-d71d-4c0d-8dca-2c7317d65d85%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Tucatinib",
   "pages": [
    {
     "brand": "Tukysa",
     "url": "https://omnirx.org/medicines/tukysa"
    }
   ],
   "labelSentence": "... in combination with trastuzumab for the treatment of adult patients with RAS wild-type HER2-positive unresectable or metastatic colorectal cancer that has progressed following treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22f27eb1b9-b7fc-424e-988f-84dd7bb195a3%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Pfizer RxPathways (Pfizer Patient Assistance Program)",
     "url": "https://omnirx.org/assistance/pfizer-rxpathways",
     "programPageIsExternal": false,
     "inCurrentList": false,
     "note": null,
     "listKind": "products remaining within Pfizer PAP as of January 1, 2026",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": null
  }
 ],
 "fundsForRelatedCosts": [
  {
   "fund": "American Cancer Society Cancer Care Continuity Fund",
   "organization": "Patient Advocate Foundation",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.patientadvocate.org/connect-with-services/financial-aid-funds/"
  },
  {
   "need": "testing",
   "fund": "Cancer genetic and genomic testing",
   "organization": "TotalAssist (Patient Advocate Foundation copay funds)",
   "status": "open",
   "readOn": "2026-11-08",
   "source": "https://totalassist.org/funds/"
  },
  {
   "need": "home care",
   "fund": "Cancer Home Care Services",
   "organization": "HealthWell Foundation",
   "status": "open",
   "readOn": "2026-11-08",
   "source": "https://www.healthwellfoundation.org/disease-funds/"
  },
  {
   "need": "behavioral health",
   "fund": "Cancer-Related Behavioral Health",
   "organization": "HealthWell Foundation",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.healthwellfoundation.org/disease-funds/"
  },
  {
   "need": "pain management",
   "fund": "Cancer-Related Pain Management",
   "organization": "CancerCare",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "need": "caregiver support",
   "fund": "CancerCare CAR-T Caregiver Assistance Fund",
   "organization": "CancerCare",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "need": "caregiver support",
   "fund": "CancerCare Caregiver Financial Assistance Fund(s)",
   "organization": "CancerCare",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "need": "clinical trial costs",
   "fund": "CancerCare Clinical Trial Financial Assistance Fund",
   "organization": "CancerCare",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "need": "transportation",
   "fund": "CancerCare Gets You There - Transportation Assistance Fund(s)",
   "organization": "CancerCare",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "need": "behavioral health",
   "fund": "Oncology Caregiver Behavioral Health Fund (Accepting phone applications only)",
   "organization": "HealthWell Foundation",
   "status": "open",
   "readOn": "2026-11-08",
   "source": "https://www.healthwellfoundation.org/disease-funds/"
  }
 ],
 "note": "Each status is what the fund page said on readOn. It is not an eligibility determination. We hold only the organizations we read; no fund here does not mean no fund exists.",
 "licence": "CC BY 4.0 for the OmniRx compilation"
}